Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-MTAB-3864

ABSTRACT: Expression profiling of normal and glioblastoma-derived neural stem cells

DISEASE(S): Glioblastoma Multiforme,Normal

PROVIDER: E-MTAB-3864 | ExpressionAtlas | 2025-01-23

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-MTAB-3864-analysis-methods.tsv	Tabular
	E-MTAB-3864-atlasExperimentSummary.Rdata	Rdata
	E-MTAB-3864-configuration.xml	Xml
	E-MTAB-3864-percentile-ranks.tsv	Tabular
	E-MTAB-3864.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 46

Similar Datasets

Expression profiling of glioblastoma neural stem cells and reprogrammed derivatives

Project description:Glioblastoma-derived neural stem (GNS) cells were reprogrammed to induced pluripotent stem (iPS) cells by transgenic expression of OCT4 and KLF4. Gene expression profiling was performed in comparison to normal neural stem (NS) cells reprogrammed in parallel, as well as standard ES cells as an independent reference.

2013-03-15 | E-MTAB-1273 | biostudies-arrayexpress

MicroRNA expression profiling of normal and glioblastoma-derived neural stem cells

Project description:MicroRNA analysis of glioblastoma-derived neural stem (GNS) cells performed in parallel with normal neural stem (NS) cell lines

2016-11-01 | E-MTAB-3865 | biostudies-arrayexpress

Expression profiling of normal and glioblastoma-derived neural stem cells

Project description:Exon array analysis of glioblastoma-derived neural stem (GNS) cells performed in parallel with normal neural stem (NS) cell lines

2015-10-01 | E-MTAB-3864 | biostudies-arrayexpress

ATAC-seq of BMP response in glioblastoma-derived neural stem cells

Project description:Chromatin accessibility was profiled by ATAC-seq in normal and glioblastoma-derived neural stem (GNS) cells, in self-renewing conditions and in response to differentiation stimulus with bone morphogenic protein (BMP).

2015-10-01 | E-MTAB-3868 | biostudies-arrayexpress

Digital expression analysis of glioma neural stem cells

Project description:High-throughput sequencing of transcript tags from normal and glioblastoma-derived neural stem cell lines

2012-09-21 | E-MTAB-971 | biostudies-arrayexpress

Lactylome of 6 Glioblastoma Stem Cells and 2 Neural Stem Cells

Project description:Lactylome of 6 Glioblastoma Stem Cells and 2 Neural Stem Cells

2025-10-27 | PXD070007 |

Proteome of 6 Glioblastoma Stem Cells and 2 Neural Stem Cells

Project description:Proteomic Analysis of 6 Glioblastoma Stem Cells and 2 Neural Stem Cells

2025-10-27 | PXD069969 |

Homo sapiens

Project description:RNA splicing alteration on glioblastoma and normal neural stem cells

| PRJNA302647 | ENA

RNA splicing alteration on glioblastoma and normal neural stem cells

Project description:We identified PHF5A as a functional synthetic-lethal hit in glioblastoma stem cells compared to normal neural stem cells. We wanted to perform analysis of RNA isoforms present in glioblastoma or normal neural stem cells with or without PHF5A depletion. We performed shRNA knockdown of PHF5A or used non-silencing shRNA as a control, selected infected cells with puromycin, and isolated RNA for sequencing.

2015-11-30 | GSE75147 | GEO

Targeting tumor-intrinsic neural vulnerabilities of glioblastoma

Project description:The neural behavior of glioblastoma, including the formation of tumor microtubes and synaptic circuitry, is increasingly understood to be pivotal for disease manifestation (Osswald et al. 2015; Venkatesh et al. 2015; Weil et al. 2017; Venkataramani et al. 2019; Venkatesh et al. 2019; Alcantara Llaguno et al. 2019; Venkataramani et al. 2022). Nonetheless, the few approved treatments for glioblastoma target its oncological nature, while its neural vulnerabilities remain incompletely mapped and clinically unexploited. Here, we systematically survey the neural molecular dependencies and cellular heterogeneity across 27 glioblastoma patients and diverse model systems. In patient tumor samples taken directly after surgery, we identify a spectrum of neural stem cell morphologies indicative of poor prognosis, and discover a set of repurposable neuroactive drugs with unexpected and consistent anti-glioma efficacy. Glioblastoma cells exhibit functional dependencies on highly expressed drug targets including neurological ion channels and receptors, while interpretable molecular machine learning reveals downstream convergence on secondary drug targets (COSTAR) involving AP-1-driven tumor suppression. COSTAR enables in silico drug screening on >1 million compounds that are validated with high accuracy. Multi-omic profiling of drug-treated glioblastoma cells confirms rapid Ca2+-driven AP-1 pathway induction to represent a tumor-intrinsic vulnerability at the intersection of oncogenesis and neural activity-dependent signaling. Finally, the consistent anti-glioma activity across patients and model systems is epitomized by the antidepressant Vortioxetine, which synergizes in vivo with approved glioblastoma chemotherapies. In all, our global analysis reveals that the neural vulnerabilities of glioblastoma converge on an AP-1 mediated gene regulatory network with direct translatable potential.

2024-08-01 | PXD037015 | panorama

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data